- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Cassling Diagnostic makes management moves
Medical imaging equipment refurbisher Cassling Diagnostic Imaging shifted its management structure this month when it appointed three new executives to posts within its organization and that of its subsidiary, Integrated Equipment Solutions. The Omaha,
Medical imaging equipment refurbisher Cassling Diagnostic Imaging shifted its management structure this month when it appointed three new executives to posts within its organization and that of its subsidiary, Integrated Equipment Solutions. The Omaha, NE, firm named Merl Dunham technical director of its imaging information and integration division. Dunham will manage CDIs integration lab and personnel and will provide technical support and integration coordination. He will report to Marty Huebner, vice president of service. CDI also appointed Randy Wobig to the post of clinical network specialist. Wobig will oversee CDIs networking department. Finally, CDIs subsidiary, Integrated Equipment Solutions, named Dale Ray vice president of sales and marketing. Ray has served as field manager for Philips Medical, vice president of sales and marketing for Fischer Imaging, and has held various management positions with Marconi Medical Systems. He will report to Gary Nie, vice president of integrated services, and will develop the companys worldwide sales force.
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.
